Therapeutic Advances in Neurological Disorders
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q1 | 77.4% | 1.243 | Q1 | 88.7% |
| 2024 | 4.1 | Q1 | 82.8% | 1.614 | Q1 | 93.1% |
| 2023 | 4.7 | Q1 | 89.1% | 1.436 | Q1 | 92.1% |
| 2022 | 5.9 | Q1 | 91.8% | 1.728 | Q1 | 94.5% |
| 2021 | 6.4 | Q1 | 89.6% | 1.447 | Q1 | 92.7% |
| 2020 | — | — | 1.684 | Q1 | 93.9% | |
| 2019 | — | — | 1.240 | Q1 | 89.8% | |
| 2018 | — | — | 1.521 | Q1 | 92.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1756-2856
ISSN
1756-2864
region
Western Europe
coverage
2008-2026